The neurochemical profile quantified by in vivo 1H NMR spectroscopy

NeuroImage

Volumn 61, Issue 2, 2012, Pages 342-362

  Duarte, João M N ^a,b   Lei, Hongxia ^a,c   Mlynárik, Vladimír ^a   Gruetter, Rolf ^a,b,c  

^a EPFL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Brain; Neurochemical profile; NMR spectroscopy

Indexed keywords

ALANINE; ASCORBIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; INOSITOL; LACTIC ACID; MINOCYCLINE; N ACETYLASPARTIC ACID; NEUROTRANSMITTER; PHOSPHOETHANOLAMINE; RILUZOLE; TAURINE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN TUMOR; CELL PROLIFERATION; DEMYELINATION; DIABETES MELLITUS; DIABETIC ENCEPHALOPATHY; ENERGY METABOLISM; GLIOSIS; GLUCOSE TRANSPORT; HUMAN; HUNTINGTON CHOREA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMAGE SELECTED IN VIVO SPECTROSCOPY; LIPID METABOLISM; LOCALIZATION BY ADIABATIC SELECTIVE REFOCUSING SPECTROSCOPY; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROCHEMISTRY; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; OSMOREGULATION; PARKINSON DISEASE; POINT RESOLVED SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCHIZOPHRENIA; SPIN ECHO FULL INTENSITY ACQUIRED LOCALIZED SPECTROSCOPY; STIMULATED ECHO ACQUISITION MODE SPECTROSCOPY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CELL PROLIFERATION; ELECTROMAGNETIC FIELDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE LIPIDS; NERVOUS SYSTEM DISEASES; NEUROTRANSMITTER AGENTS; SPECIES SPECIFICITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84860713083     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.038     Document Type: Review

References (333)

1. Abildgaard F., Gesmar H., Led J.J. Quantitative analysis of complicated nonideal Fourier transform NMR spectra. J. Magn. Reson. 1988, 79:78-89.
2. Adriany G., Van de Moortele P.F., Ritter J., Moeller S., Auerbach E.J., Akgun C., Snyder C.J., Vaughan T., Ugurbil K. A geometrically adjustable 16-channel transmit/receive transmission line array for improved RF efficiency and parallel imaging performance at 7Tesla. Magn. Reson. Med. 2008, 59:590-597.
3. Albrecht J., Schousboe A. Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem. Res. 2005, 30:1615-1621.
4. Albright C.D., Siwek D.F., Craciunescu C.N., Mar M.H., Kowall N.W., Williams C.L., Zeisel S.H. Choline availability during embryonic development alters the localization of calretinin in developing and aging mouse hippocampus. Nutr. Neurosci. 2003, 6(2):129-134.
5. Alf, F.M, Lei, H., Berthet, C., Hirt, L., Gruetter, R., Mlynarik, V., 2011. High-resolution spatial mapping of changes in the neurochemical profile after focal ischemia in mice. NMR Biomed. 2011 Jul 15. doi:. [Epub ahead of print]. doi:10.1002/nbm.1740.
6. An L., Zhang Y., Thomasson D.M., Latour L.L., Baker E.H., Shen J., Warach S. Measurement of glutathione in normal volunteers and stroke patients at 3T using J-difference spectroscopy with minimized subtraction errors. J. Magn. Reson. Imaging 2009, 30:263-270.
7. Anderson S.A., Classey J.D., Condé F., Lund J.S., Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 1995, 67(1):7-22.
8. Andreassen O.A., Jenkins B.G., Dedeoglu A., Ferrante K.L., Bogdanov M.B., Kaddurah-Daouk R., Beal M.F. Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J. Neurochem. 2001, 77:383-390.
9. Angelie E., Bonmartin A., Boudraa A., Gonnaud P.M., Mallet J.J., Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. Am. J. Neuroradiol. 2001, 22:119-127.
10. Avdievich N.I., Oh S., Hetherington H.P., Collins C.M. Improved homogeneity of the transmit field by simultaneous transmission with phased array and volume coil. J. Magn. Reson. 2010, 32:476-481.
11. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009, 390:191-214.
12. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003, 28:941-953.
13. Baydas G., Nedzvetskii V.S., Tuzcu M., Yasar A., Kirichenko S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 2003, 462:67-71.
14. Bayer S.M., McMurray W.C. The metabolism of amino acids in developing rat brain. J. Neurochem. 1967, 14:695-706.
15. 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am. J. Psychiatry 1999, 156:952-954.
16. Benítez-Diaz P., Miranda-Contreras L., Mendoza-Briceño R.V., Peña-Contreras Z., Palacios-Prü E. Prenatal and postnatal contents of amino acid neurotransmitters in mouse parietal cortex. Dev. Neurosci. 2003, 25:366-374.
17. Berthet C., Lei H., Thevenet J., Gruetter R., Magistretti P.J., Hirt L. Neuroprotective role of lactate after cerebral ischemia. J. Cereb. Blood Flow Metab. 2009, 29:1780-1789.
18. Berthet C., Lei H., Gruetter R., Hirt L. Early predictive biomarkers for lesion after transient cerebral ischemia. Stroke 2011, 42:799-805.
19. Betz H., Laube B. Glycine receptors: recent insights into their structural organization and functional diversity. J. Neurochem. 2006, 97:1600-1610.
20. 1H magnetic resonance spectroscopy. NMR Biomed. 2004, 17:60-68.
21. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45:1259-1266.
22. Bitsch A., Bruhn H., Vougioukas V., Stringaris A., Lassmann H., Frahm J., Brück W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am. J. Neuroradiol. 1999, 20:1619-1627.
23. 31P MRS in in vivo human brain. Magn. Reson. Med. 1999, 42:643-654.
24. Boer V.O., Siero J.C., Hoogduin H., van Gorp J.S., Luijten P.R., Klomp D.W. High-field MRS of the human brain at short TE and TR. NMR Biomed 2011, 24:1081-1088.
25. Boesch C., Gruetter R., Martin E. Temporal and spatial analysis of fields generated by eddy currents in superconducting magnets: optimization of corrections and quantitative characterization of magnet/gradient systems. Magn. Reson. Med. 1991, 20:268-284.
26. Boesch S.M., Schocke M., Bürk K., Hollosi P., Fornai F., Aichner F.T., Poewe W., Felber S. Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6. J. Magn. Reson. Imaging 2001, 13:553-559.
27. Boesch S.M., Wolf C., Seppi K., Felber S., Wenning G.K., Schocke M. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging. J. Magn. Reson. Imaging 2007, 25:564-569.
28. 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. J. Neurosci. 2005, 25:1691-1700.
29. Bothwell J.H., Rae C., Dixon R.M., Styles P., Bhakoo K.K. Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo. J. Neurochem. 2001, 77:1632-1640.
30. Bottomly, P.A 1984. Selective volume method for performing localized NMR spectroscopy. US patent 4 480 228.
31. Bottomly P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987, 508:333-348.
32. Bowtell R., Mansfield P. Gradient coil design using active magnetic screening. Magn. Reson. Med. 1991, 17:15-19.
33. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 1993, 15:289-298.
34. Brown T.R., Kincaid B.M., Ugurbil K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:3523-3526.
35. Brownell A.L., Jenkins B.G., Elmaleh D.R., Deacon T.W., Spealman R.D., Isacson O. Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease. Nat. Med. 1998, 4:1308-1312.
36. Bruhn H., Frahm J., Gyngell M.L., Merboldt K.D., Hänicke W., Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn. Reson. Med. 1989, 9:126-131.
37. Brulatout S., Méric P., Loubinoux I., Borredon J., Corrèze J.L., Roucher P., Gillet B., Bérenger G., Beloeil J.C., Tiffon B., Mispelter J., Seylaz J. A one-dimensional (proton and phosphorus) and two-dimensional (proton) in vivo NMR spectroscopic study of reversible global cerebral ischemia. J. Neurochem. 1996, 66:2491-2499.
38. Burlina A.P., Skaper S.D., Mazza M.R., Ferrari V., Leon A., Burlina A.B. N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-d-aspartic acid in vitro. J. Neurochem. 1994, 63:1174-1177.
39. 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods. Neurochem. Res. 1990, 15:1009-1016.
40. Burri R., Steffen C., Herschkowitz N. N-acetyl-l-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci. 1991, 13:403-411.
41. 1H-MRS at 4Tesla in minimally treated early schizophrenia. Mol. Psychiatry 2009, 15(6):629-636.
42. Camicioli R.M., Hanstock C.C., Bouchard T.P., Gee M., Fisher N.J., Martin W.R. Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease. Mov. Disord. 2007, 22:382-386.
43. Cassidy M., Neale J.H. N-Acethylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia. Neuropeptides 1993, 24:271-278.
44. Castro M.A., Beltran F.A., Brauchi S., Concha I.I. A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J. Neurochem. 2009, 110:423-440.
45. 13C NMR. J. Biol. Chem. 1990, 265:12916-12926.
46. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 2001, 78:736-745.
47. Chang L., Ernst T., Poland R.E., Jenden D.J. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci. 1996, 58:2049-2056.
48. Chantal S., Labelle M., Bouchard R.W., Braun C.M., Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch. Neurol. 2002, 59:955-962.
49. Chantal S., Braun C.M., Bouchard R.W., Labelle M., Boulanger Y. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res. 2004, 1003:26-35.
50. Chassain C., Bielicki G., Durand E., Lolignier S., Essafi F., Traoré A., Durif F. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse. J. Neurochem. 2008, 105:874-882.
51. 1H MRS in the MPTP-intoxicated mouse. NMR Biomed. 2010, 23:547-553.
52. Chen W., Novotny E.J., Zhu X.H., Rothman D.L., Shulman R.G. Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9896-9900.
53. Chen W., Zhu X.H., Gruetter R., Seaquist E.R., Adriany G., Ugurbil K. Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using 1H-[13C] MRS and fMRI. Magn. Reson. Med. 2001, 45:349-355.
54. Chen S.Q., Wang P.J., Ten G.J., Zhan W., Li M.H., Zang F.C. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement. Geriatr. Cogn. Disord. 2009, 28:558-566.
55. Choi I.Y., Lei H., Gruetter R. Effect of deep pentobarbital anesthesia on neurotransmitter metabolism in vivo: on the correlation of total glucose consumption with glutamatergic action. J. Cereb. Blood Flow Metab. 2002, 22:1343-1351.
56. Choi I.Y., Lee S.P., Shen J. Selective homonuclear Hartmann-Hahn transfer method for in vivo spectral editing in the human brain. Magn. Reson. Med. 2005, 53:503-510.
57. Choi J.K., Jenkins B.G., Carreras I., Kaymakcalan S., Cormier K., Kowall N.W., Dedeoglu A. Anti-inflammatory treatment in AD mice protects against neuronal pathology. Exp. Neurol. 2010, 223:377-384.
58. 1H-MRS study of an animal model for Parkinson's disease. Magn. Reson. Imaging 2011, 29:32-39.
59. Choo Y.S., Mao Z., Johnson G.V., Lesort M. Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model. Neurosci. Lett. 2005, 386:63-68.
60. Clarke C.E., Lowry M. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Eur. J. Neurol. 2001, 8:573-577.
61. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab. Brain Dis. 2002, 17:415-429.
62. Costantino-Ceccarini E., Morell P. Biosynthesis of brain sphingolipids and myelin accumulation in the mouse. Lipids 1972, 7:656-659.
63. Craciunescu C.N., Albright C.D., Mar M.H., Song J., Zeisel S.H. Choline availability during embryonic development alters progenitor cell mitosis in developing mouse hippocampus. J. Nutr. 2003, 133(11):3614-3618.
64. 1 relaxation times of the neurochemical profile in rat brain at 9.4Tesla and 14.1Tesla. Magn. Reson. Med. 2009, 62:862-867.
65. Cudalbu, C., Lanz, B., Duarte, J.M., Morgenthaler, F.D., Pilloud, Y., Mlynárik, V., Gruetter, R., 2011. Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized (1)H and (15)N NMR spectroscopy. J Cereb Blood Flow Metab. 2011 Dec 14. doi:. [Epub ahead of print]. doi:10.1038/jcbfm.2011.173.
66. Cvoro V., Wardlaw J.M., Marshall I., Armitage P.A., Rivers C.S., Bastin M.E., Carpenter T.K., Wartolowska K., Farrall A.J., Dennis M.S. Associations between diffusion and perfusion parameters, N-acetyl aspartate, and lactate in acute ischemic stroke. Stroke 2009, 40:767-772.
67. Cwik V.A., Hanstock C.C., Allen P.S., Martin W.R. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998, 50:72-77.
68. D'Abreu A., França M., Appenzeller S., Lopes-Cendes I., Cendes F. Axonal dysfunction in the deep white matter in Machado-Joseph disease. J. Neuroimaging 2009, 19:9-12.
69. D'Adamo A.F., Yatsu F.M. Acetate metabolism in the nervous system. N-acetyl-l-aspartic acid and the biosynthesis of brain lipids. J. Neurochem. 1966, 13:961-965.
70. de Graaf R.A. In vivo NMR spectroscopy. Principles and Techniques 2008, John Wiley, Chichester. Second edition.
71. 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting. Magn. Reson. Med. 1990, 15:305-319.
72. 2 relaxation in rat brain in vivo. Magn. Reson. Med. 2006, 56:386-394.
73. 1H NMR spectra from rat brain extracts. Anal. Chem. 2011, 83:216-224.
74. De Stefano N., Matthews P.M., Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 1995, 34:721-727.
75. Dedeoglu A., Choi J.K., Cormier K., Kowall N.W., Jenkins B.G. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res. 2004, 1012:60-65.
76. 1H NMR spectroscopy of the human brain at 9.4T: initial results. J. Magn. Reson. 2010, 206:74-80.
77. del Olmo N., Galarreta M., Bustamante J., Martín del Rio R., Solís J.M. Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 2000, 39:40-54.
78. Dienel G.A., Wang R.Y., Cruz N.F. Generalized sensory stimulation of conscious rats increases labeling of oxidative pathways of glucose metabolism when the brain glucose-oxygen uptake ratio rises. J. Cereb. Blood Flow Metab. 2002, 22:1490-1502.
79. Do K.Q., Trabesinger A.H., Kirsten-Krüger M., Lauer C.J., Dydak U., Hell D., Holsboer F., Boesiger P., Cuénod M. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur. J. Neurosci. 2000, 12:3721-3728.
80. Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 2009, 19:220-230.
81. Doelken M.T., Hammen T., Bogner W., Mennecke A., Stadlbauer A., Boettcher U., Doerfler A., Stefan H. Alterations of intracerebral γ-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies. Epilepsia 2010, 51:1477-1482.
82. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 2000, 62:649-671.
83. 2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem. Int. 2006, 48:144-150.
84. Duarte J.M.N., Carvalho R.A., Cunha R.A., Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J. Neurochem. 2009, 111:368-379.
85. Duarte J.M.N., Morgenthaler F.D., Lei H., Poitry-Yamate C., Gruetter R. Steady-state brain glucose transport kinetics re-evaluated with a four-state conformational model. Front Neuroenerg. 2009, 1:6.
86. Duarte J.M.N., Carvalho R.A., Cunha R.A., Gruetter R. Effect of long-term caffeine consumption on glucose transport and osmolarity alterations in the hippocampus of STZ-induced and Goto-Kakizaki diabetic rats: in vivo 1H MRS study at 9.4T. Proc. Int. Soc. Magn. Reson. Med. 2009, 17:1084.
87. Duarte, J.M., Kulak, A., Gholam-Razaee, M.M., Cuenod, M., Gruetter, R., Do, K.Q. N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development.Biol Psychiatry. 2011 Sep 25. [Epub ahead of print].
88. Eldridge C.F., Bunge M.B., Wood P.M. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J. Cell Biol. 1987, 105:1023-1034.
89. Ferreira I.L., Resende R., Ferreiro E., Rego A.C., Pereira C.F. Multiple defects in energy metabolism in Alzheimer's disease. Curr. Drug Targets 2010, 11:1193-1206.
90. Flint A.C., Liu X., Kriegstein A.R. Nonsynaptic glycine receptor activation during early neocortical development. Neuron 1998, 20:43-53.
91. Frahm J., Krüger G., Merboldt K.D., Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn. Reson. Med. 1996, 35:143-148.
92. França M.C., D'Abreu A., Yasuda C.L., Bonadia L.C., Santos da Silva M., Nucci A., Lopes-Cendes I., Cendes F. A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia. J. Neurol. 2009, 256:1114-1120.
93. 1H NMR measurement of glycine in rat brain at 9.4T at short echo time. Magn. Reson. Med. 2008, 60:727-731.
94. 1H MRS in human brain at 7T. MAGMA 2009, 22:1-4.
95. Garwood M., Ke Y. Symmetric pulses to induce arbitrary flip angles with compensation for rf inhomogeneity and resonance offsets. J Magn Reson 1991, 94:511-525.
96. Garwood M., DelaBarre L. The return of the frequency sweep: designing adiabatic pulse for contemporary NMR. J. Magn. Reson. 2001, 153:155-177.
97. Geissler A., Frund R., Scholmerich J., Feuerbach S., Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp. Clin. Endocrinol. Diabetes 2003, 111:421-427.
98. Gideon P., Henriksen O., Sperling B., Christiansen P., Olsen T.S., Jørgensen H.S., Arlien-Søborg P. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke 1992, 23:1566-1572.
99. Gideon P., Sperling B., Arlien-Søborg P., Olsen T.S., Henriksen O. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke 1994, 25:967-973.
100. Ginefri J.C., Poirier-Quinot M., Girard O., Darrasse L. Technical aspects: development, manufacture and installation of a cryo-cooled HTS coil system for high resolution in-vivo imaging of the mouse at 1.5T. Methods 2007, 43:54-67.
101. Glanville N.T., Byers D.M., Cook H.W., Spence M.W., Palmer F.B. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim. Biophys. Acta 1989, 1004:169-179.
102. 1H-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2001, 58:556-561.
103. Gredal O., Rosenbaum S., Topp S., Karlsborg M., Strange P., Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997, 48:878-881.
104. Griffith H.R., Okonkwo O.C., O'Brien T., Hollander J.A. Reduced brain glutamate in patients with Parkinson's disease. NMR Biomed. 2008, 21:381-387.
105. Grillo C.A., Piroli G.G., Wood G.E., Reznikov L.R., McEwen B.S., Reagan L.P. Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 2005, 136:477-486.
106. Gruber S., Pinker K., Riederer F., Chmelík M., Stadlbauer A., Bittsanský M., Mlynárik V., Frey R., Serles W., Bodamer O., Moser E. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur. J. Radiol. 2008, 68:320-327.
107. Gruetter R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magn. Reson. Med. 1993, 29:804-811.
108. Gruetter R., Boesch C. Fast, non-interactive shimming on spatially localized signals: in vivo analysis of the magnetic field along axes. J. Magn. Reson. 1992, 96:323-334.
109. Gruetter R., Tkáč I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn. Reson. Med. 2000, 43:319-323.
110. 1H NMR studies of glucose transport in the human brain. J. Cereb. Blood Flow Metab. 1996, 16:427-438.
111. Gruetter R., Ugurbil K., Seaquist E.R. Steady-state cerebral glucose concentrations and transport in the human brain. J. Neurochem. 1998, 70:397-408.
112. 13C NMR spectroscopy of the brain. NMR Biomed. 2003, 16:313-338.
113. Guerrini L., Belli G., Mazzoni L., Foresti S., Ginestroni A., Della Nave R., Diciotti S., Mascalchi M. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias. J. Magn. Reson. Imaging 2009, 30:11-17.
114. Gupta R.C., D'Archivio M., Masella R. Taurine as drug and functional food component. Glutathione and Sulfur Amino Acids in Human Health and Disease 2009, John Willey and Sons. R. Masella, G. Mazza (Eds.).
115. 31P-NMR on developing dog brain. FEBS Lett. 1984, 178:137-142.
116. Hahn E.L. Spin echoes. Phys. Rev. 1950, 80:580-594.
117. Haley A.P., Knight-Scott J., Simnad V.I., Manning C.A. Increased glucose concentration in the hippocampus in early Alzheimer's disease following oral glucose ingestion. Magn. Reson. Imaging 2006, 24:715-720.
118. Han J., Ma L. Study of the features of proton MR spectroscopy (1H-MRS) on amyotrophic lateral sclerosis. J. Magn. Reson. Imaging 2010, 31:305-308.
119. Hattingen E., Magerkurth J., Pilatus U., Mozer A., Seifried C., Steinmetz H., Zanella F., Hilker R. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced. Park. Dis. 2009, 132:3285-3297.
120. Henchcliffe C., Shungu D.C., Mao X., Huang C., Nirenberg M.J., Jenkins B.G., Beal M.F. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease. Ann. N. Y. Acad. Sci. 2008, 1147:206-220.
121. 1-insensitive outer-volume suppression at 3T. Magn. Reson. Med. 2008, 59:40-51.
122. Hertz L. Glutamate, a neurotransmitter - and so much more. A synopsis of Wierzba III. Neurochem. Int. 2006, 48:416-425.
123. 1H spectroscopic imaging. Magn. Reson. Med. 2006, 56:26-33.
124. Hetherington H.P., Avdievich N.I., Kunznetsov Pan J.W. RF shimming for spectroscopic localization in the human brain at 7T. Magn. Reson. Med. 2010, 63:9-19.
125. 1H NMR spectroscopy at 16.4T. Magn. Reson. Med. 2011, 65:28-34.
126. Horská A., Farage L., Bibat G., Nagae L.M., Kaufmann W.E., Barker P.B., Naidu S. Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann. Neurol. 2009, 65:90-97.
127. Hou Z., Lei H., Hong S., Sun B., Fang K., Lin X., Liu M., Yew D.T., Liu S. Functional changes in the frontal cortex in Parkinson's disease using a rat model. J. Clin. Neurosci. 2010, 17:628-633.
128. Hoult D., Richards R. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J. Magn. Reson. 1976, 24:71-85.
129. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003, 16:123-131.
130. Huang W., Alexander G.E., Chang L., Shetty H.U., Krasuski J.S., Rapoport S.I., Schapiro M.B. Brain metabolite concentration and dementia severity in Alzheimer's disease: a 1H MRS study. Neurology 2001, 57:626-632.
131. 13C]NMR. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:7612-7617.
132. 13C] nuclear magnetic resonance study. J. Cereb. Blood Flow Metab. 1997, 17:1040-1047.
133. 1H MRS study. NMR Biomed. 2009, 22:737-744.
134. Iltis I., Hutter D., Bushara K.O., Clark H.B., Gross M., Eberly L.E., Gomez C.M., Oz G. 1H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Res. 2010, 1358:200-210.
135. Jack C.R., Marjanska M., Wengenack T.M., Reyes D.A., Curran G.L., Lin J., Preboske G.M., Poduslo J.F., Garwood M. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Neuroscientist 2007, 13:38-48.
136. Jayakumar P.N., Srikanth S.G., Chandrashekar H.S., Kovoor J.M., Shankar S.K., Anandh B. Pyruvate: an in vivo marker of cestodal infestation of the human brain on proton MR spectroscopy. J. Magn. Reson. Imaging 2003, 18:675-680.
137. Jehensen P., Westphal M., Schuff N. Analytical method for the compensation of eddy-current effects induced by pulsed magnetic field gradients in NMR systems J Magn Reson 1990, 90:264-278.
138. Jenkins B.G., Brouillet E., Chen Y.C., Storey E., Schulz J.B., Kirschner P., Beal M.F., Rosen B.R. Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. Cereb. Blood Flow Metab. 1996, 16:450-461.
139. Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., Beal M.F. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J. Neurochem. 2000, 74:2108-2119.
140. Jenkins B.G., Andreassen O.A., Dedeoglu A., Leavitt B., Hayden M., Borchelt D., Ross C.A., Ferrante R.J., Beal M.F. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. J. Neurochem. 2005, 95:553-562.
141. Jessen F., Block W., Träber F., Keller E., Flacke S., Papassotiropoulos A., Lamerichs R., Heun R., Schild H.H. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000, 55:684-688.
142. Jessen F., Gür O., Block W., Ende G., Frölich L., Hammen T., Wiltfang J., Kucinski T., Jahn H., Heun R., Maier W., Kölsch H., Kornhuber J., Träber F. A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI. Neurology 2009, 72:1735-1740.
143. 1H MRS detection of glycine residue of reduced glutathione in vivo. J. Magn. Reson. 2010, 202:259-266.
144. Kalra S., Cashman N.R., Genge A., Arnold D.L. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998, 9:1757-1761.
145. Kalra S., Cashman N.R., Caramanos Z., Genge A., Arnold D.L. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. AJNR Am. J. Neuroradiol. 2003, 24:476-480.
146. Kalra S., Tai P., Genge A., Arnold D.L. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J. Neurol. 2006, 253:1060-1063.
147. 1H magnetic resonance spectroscopy in dementia. Br. J. Radiol. 2007, 80:S146-S152.
148. Kantarci K., Petersen R.C., Boeve B.F., Knopman D.S., Tang-Wai D.F., O'Brien P.C., Weigand S.D., Edland S.D., Smith G.E., Ivnik R.J., Ferman T.J., Tangalos E.G., Jack C.R. 1H MR spectroscopy in common dementias. Neurology 2004, 63:1393-1398.
149. Kantarci K., Weigand S.D., Petersen R.C., Boeve B.F., Knopman D.S., Gunter J., Reyes D., Shiung M., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Jack C.R. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2007, 28:1330-1339.
150. Katscher U., Bornert P., Leussler C., van den Brink J.S. Transmit SENSE. Magn. Reson. Med. 2003, 49:144-150.
151. Katscher U., Rohrs J., Bornert P. Basic considerations on the impact of the coil array on the performance of transmit SENSE. MAGMA 2005, 18:81-88.
152. Ke Y., Streeter C.C., Nassar L.E., Sarid-Segal O., Hennen J., Yurgelun-Todd D.A., Awad L.A., Rendall M.J., Gruber S.A., Nason A., Mudrick M.J., Blank S.R., Meyer A.A., Knapp C., Ciraulo D.A., Renshaw P.F. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res. 2004, 130:283-293.
153. Khiat A., D'Amour M., Souchon F., Boulanger Y. MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS. Magn. Reson. Imaging 2010, 28:1456-1460.
154. Kickler N., van der Zwaag W., Merkle R., Kober T., Marques J.P., Krueger G., Gruetter R. Eddy current effects on a clinical 7T-68cm bore scanner. MAGMA 2010, 23:39-43.
155. 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am. J. Neuroradiol. 2005, 26:752-759.
156. Kinoshita Y., Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997, 10:2-12.
157. Kirkham F.J., Datta A.K. Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev. Sci. 2006, 9:411-427.
158. Kirmani B.F., Jacobowitz D.M., Kallarakal A.T., Namboodiri M.A. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res. Mol. Brain Res. 2002, 107:176-182.
159. Klapstein G.J., Fisher R.S., Zanjani H., Cepeda C., Jokel E.S., Chesselet M.F., Levine M.S. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 2001, 86:2667-2677.
160. Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J. Neural Transm. 2000, 107:1027-1063.
161. Klunk W.E., Panchalingam K., McClure R.J., Stanley J.A., Pettegrew J.W. Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4. Neurobiol. Aging 1998, 19:511-515.
162. 1H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice. Eur. J. Neurosci. 2006, 23:1077-1081.
163. Kohli A., Gupta R.K., Poptani H., Roy R. In vivo proton magnetic resonance spectroscopy in a case of intracranial hydatid cyst. Neurology 1995, 45:562-564.
164. Koller K.J., Coyle J.T. Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain. Brain Res. 1984, 317:137-140.
165. Kreis R., Ross B.D. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992, 184:123-130.
166. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed. 1991, 4:109-116.
167. Kreis R., Ernst T., Ross B.D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn. Reson. Med. 1993, 30:424-437.
168. Kulak, A., Duarte, J.M., Do, K.Q., Gruetter, R., 2010. Neurochemical profile of the developing mouse cortex determined by in vivo 1H NMR spectroscopy at 14.1 T and the effect of recurrent anaesthesia. J Neurochem 115(6):1466-77.
169. Kunz N., Camm E.J., Somm E., Lodygensky G., Darbre S., Aubert M.L., Hüppi P.S., Sizonenko S.V., Gruetter R. Developmental and metabolic brain alterations in rats exposed to bisphenol A during gestation and lactation. Int. J. Dev. Neurosci. 2011, 29:37-43.
170. 1H-MRS study. Brain Res. 1995, 670:326-328.
171. Kwok W.E., You Z. In vivo MRI using liquid nitrogen cooled phasaed array coil at 3.0T. Magn. Reson. Imaging 2006, 24:819-823.
172. Lahoya J.L., Benavides J., Ugarte M. Glycine metabolism and glycine synthase activity during the postnatal development of rat brain. Dev. Neurosci. 1980, 3:75-80.
173. Lee W.T., Chang C. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. Prog. Neurobiol. 2004, 72:87-110.
174. 13C NMR study. J. Neurochem. 2006, 99:260-268.
175. Lei H., Mlynárik V., Just N., Gruetter R. Snapshot gradient-recalled echo-planar images with very long echo time of rat brain at 9.4-T. Magn. Reson. Imaging 2008, 26:954-960.
176. Lei H., Berthet C., Hirt L., Gruetter R. Evolution of the neurochemical profile after transient focal cerebral ischemia in the mouse brain. J. Cereb. Blood Flow Metab. 2009, 29:811-819.
177. Lei H., Duarte J.M.N., Mlynarik V., Python A., Gruetter R. Deep thiopental anesthesia alters steady-state glucose homeostasis but not the neurochemical profile of rat cortex. J. Neurosci. Res. 2010, 88:413-419.
178. 1H MRS at 14.1T. NMR Biomed. 2010, 23:578-583.
179. Lei H., Dirren E., Poitry-Yamate C., Schneider B.L., Aebishcer P., Gruetter R. Early metabolic changes in the amyotrophic lateral sclerosis SOD1 mouse brain are revealed using 1H MRS rather than CASL and 18FDG PET. Proceedings 19th Scientific Meeting of the International Society for Magnetic Resonance in Medicine 2011, 2284.
180. Li Y., Chen A.P., Crane J.C., Chang S.M., Vigneron D.B., Nelson S.J. Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T. Magn. Reson. Med. 2007, 58:886-892.
181. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
182. Löbel U., Ellison D.W., Shulkin B.L., Patay Z. Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child. Clin. Radiol. 2011, 66:194-201.
183. 1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurol. Sci. 2001, 22:69-70.
184. Lucetti C., Del Dotto P., Gambaccini G., Ceravolo R., Logi C., Berti C., Rossi G., Bianchi M.C., Tosetti M., Murri L., Bonuccelli U. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study. Mov. Disord. 2007, 22:2170-2175.
185. Lust W.D., Pundik S., Zechel J., Zhou Y., Buczek M., Selman W.R. Changing metabolic and energy profiles in the fetal, neonatal, and adult rat brain. Metab. Brain Dis. 2003, 18:195-206.
186. Lutkenhoff E.S., van Erp T.G., Thomas M.A., Therman S., Manninen M., Huttunen M.O., Kapiro J., Lönnqvist J., O'Neill J., Cannon T.D. Proton MRS in twin pairs discordant for schizophrenia. Mol. Psychiatry 2008, 15(3):308-318.
187. Lykkesfeldt J. Increased oxidative damage in vitamin C deficiency is accompanied by induction of ascorbic acid recycling capacity in young but not mature guinea pigs. Free Radic. Res. 2002, 36:567-574.
188. Lykkesfeldt J., Trueba G.P., Poulsen H.E., Christen S. Vitamin C deficiency in weanling guinea pigs: differential expression of oxidative stress and DNA repair in liver and brain. Br. J. Nutr. 2007, 98:1116-1119.
189. Lynch G.W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 2004, 84:1051-1095.
190. Ma Q.Y., Chan K.C., Kacher D.F., Gao E., Chow M.S., Wong K.K., Xu H., Yang E.S., Miller J.R., Jolesz F.A. Superconducting RF coils for clinical MR imaging at low field. Acad. Radiol. 2003, 10:978-987.
191. 1H NMR spectroscopy in the human visual cortex. J. Cereb. Blood Flow Metab. 2007, 27:1055-1063.
192. Manos P., Bryan G.K., Edmond J. Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes. J. Neurochem. 1991, 56:2101-2107.
193. Mansfield P., Chapman B. Active magnetic screening of gradient coils in NMR imaging. J. Magn. Reson. 1986, 66:573-576.
194. Marjanska M., Curran G.L., Wengenack T.M., Henry P.G., Bliss R.L., Poduslo J.F., Jack C.R., Ugurbil K., Garwood M. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11906-11910.
195. Martin H.L., Teismann P. Glutathione - a review on its role and significance in Parkinson's disease. FASEB J. 2009, 23:3263-3272.
196. Mascalchi M., Cosottini M., Lolli F., Salvi F., Tessa C., Macucci M., Tosetti M., Plasmati R., Ferlini A., Tassinari C.A., Villari N. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. Radiology 2002, 223:371-378.
197. Mason G.F., Behar K.L., Rothman D.L., Shulman R.G. NMR determination of intracerebral glucose concentration and transport kinetics in rat brain. J. Cereb. Blood Flow Metab. 1992, 12:448-455.
198. Matsuzawa D., Hashimoto K. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid. Redox Signal. 2011, epub ahead of print 4 December 2010. 10.1089/ars.2010.3453.
199. McKenna M.C. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 2007, 85:3347-3358.
200. Mekle R., Mlynárik V., Gambarota G., Hergt M., Krueger G., Gruetter R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn. Reson. Med. 2009, 61:1279-1285.
201. Merboldt K.D., Bruhn H., Hänicke W., Michaelis T., Frahm J. Decrease of glucose in the human visual cortex during photic stimulation. Magn. Reson. Med. 1992, 25:187-194.
202. Mescher M., Merkle H., Kirsch J., Garwood M., Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998, 11:266-272.
203. Meyerhoff D.J., MacKay S., Constans J.M., Norman D., Van Dyke C., Fein G., Weiner M.W. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 1994, 36:40-47.
204. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., Ross B.D. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993, 187:433437.
205. Miyasaka N., Takahashi K., Heterington H.P. Fully automated shim mapping method for spectroscopic imaging of the mouse brain at 11.7Tesla. Magn. Reson. Med. 2006, 55:198-202.
206. Mlynárik V., Gambarota G., Frenkel H., Gruetter R. Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn. Reson. Med. 2006, 56:965-970.
207. 1H NMR spectroscopy of rat brain in vivo at 14.1Tesla: improvements in quantification of the neurochemical profile. J. Magn. Reson. 2008, 194:163-168.
208. Mlynárik V., Kohler I., Gambarota G., Vaslin A., Clarke P.G., Gruetter R. Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra-short echo times. Magn. Reson. Med. 2008, 59:52-58.
209. Mohanakrishnan P., Fowler A.H., Vonsattel J.P., Jolles P.R., Husain M.M., Liem P., Myers L., Komoroski R.A. Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum. J. Gerontol. Series A Biol. Sci. Med. Sci. 1997, 52:B111-B117.
210. Möller-Hartmann W., Herminghaus S., Krings T., Marquardt G., Lanfermann H., Pilatus U., Zanella F.E. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002, 44:371-381.
211. Mukherjee P., Bahn M.M., McKinstry R.C., Shimony J.S., Cull T.S., Akbudak E., Snyder A.Z., Conturo T.E. Differences between gray matter and white matter water diffusion in stroke: diffusion-tensor MR imaging in 12 patients. Radiology 2000, 215:211-220.
212. Muse E.D., Jurevics H., Toews A.D., Matsushima G.K., Morell P. Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 2001, 76:77-86.
213. Naressi A., Couturier C., Devos J.M., Janssen M., Mangeat C., de Beer R., Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001, 12:141-152.
214. Nehlig A. Brain uptake and metabolism of keton bodies in animal models. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:265-275.
215. Nelles M., Block W., Träber F., Wüllner U., Schild H.H., Urbach H. Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease. AJNR Am. J. Neuroradiol. 2008, 29:1708-1714.
216. Niessen H.G., Debska-Vielhaber G., Sander K., Angenstein F., Ludolph A.C., Hilfert L., Willker W., Leibfritz D., Heinze H.J., Kunz W.S., Vielhaber S. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2007, 25:1669-1677.
217. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:1671-1675.
218. Oberg J., Spenger C., Wang F.H., Andersson A., Westman E., Skoglund P., Sunnemark D., Norinder U., Klason T., Wahlund L.O., Lindberg M. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol. Aging 2008, 29:1423-1433.
219. Oliveira J.M. Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration. J. Bioenerg. Biomembr. 2010, 42:227-234.
220. Ordidge R.J., Connelly A., Lohman J.A. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 1986, 66:283-294.
221. Oz G., Tkáč I. Short-echo, single-shot, full-intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: validation in the cerebellum and brainstem. Magn Reson Med 2011, 65:901-910.
222. Oz G., Terpstra M., Tkác I., Aia P., Lowary J., Tuite P.J., Gruetter R. Proton MRS of the unilateral substantia nigra in the human brain at 4Tesla: detection of high GABA concentrations. Magn. Reson. Med. 2006, 55:296-301.
223. Oz G., Hutter D., Tkác I., Clark H.B., Gross M.D., Jiang H., Eberly L.E., Bushara K.O., Gomez C.M. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov. Disord. 2010, 25:1253-1261.
224. Oz G., Nelson C.D., Koski D.M., Henry P.G., Marjanska M., Deelchand D.K., Shanley R., Eberly L.E., Orr H.T., Clark H.B. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J. Neurosci. 2010, 30:3831-3838.
225. Oz G., Iltis I., Hutter D., Thomas W., Bushara K.O., Gomez C.M. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum 2010, 2010 Sep 14. [Epub ahead of print].
226. Pan J.W., Telang F.W., Lee J.H., de Graaf R.A., Rothman D.L., Stein D.T., Hetherington H.P. Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J. Neurochem. 2001, 79:539-544.
227. 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000, 55:498-505.
228. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:10625-10629.
229. Pereira A.C., Saunders D.E., Doyle V.L., Bland J.M., Howe F.A., Griffiths J.R., Brown M.M. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke 1999, 30:1577-1582.
230. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., Lim K.O. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn. Reson. Med. 1999, 41:276-284.
231. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., Lim K.O. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch. Gen. Psychiatry 1999, 56:185-192.
232. 1H NMR spectra of the rat brain. J. Magn. Reson. 1999, 141:104-120.
233. Pilatus U., Lais C., Rochmont Adu M., Kratzsch T., Frölich L., Maurer K., Zanella F.E., Lanfermann H., Pantel J. Conversion to dementia in mild cognitive impairment is associated with decline of N-acetylaspartate and creatine as revealed by magnetic resonance spectroscopy. Psychiatry Res. 2009, 173:1-7.
234. Pioro E.P., Antel J.P., Cashman N.R., Arnold D.L. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994, 44:1933-1938.
235. Pioro E.P., Wang Y., Moore J.K., Ng T.C., Trapp B.D., Klinkosz B., Mitsumoto H. Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry. Neuroreport 1998, 9:3041-3046.
236. 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 1999, 53:71-79.
237. Podell M., Hadjiconstantinou M., Smith M.A., Neff N.H. Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism. Exp. Neurol. 2003, 179:159-166.
238. Pohl C., Block W., Karitzky J., Träber F., Schmidt S., Grothe C., Lamerichs R., Schild H., Klockgether T. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch. Neurol. 2001, 58:729-735.
239. Pouwels P.J., Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med. 1998, 39:53-60.
240. 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:5829-5831.
241. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993, 30:672-679.
242. Qiu S., Li L., Weeber E.J., May J.M. Ascorbate transport by primary cultured neurons and its role in the neuronal function and protection against excitotoxicity. J. Neurosci. Res. 2007, 85:1046-1056.
243. Quarles R.H., Macklin W.B., Morell P. Myelin formation, structure and biochemistry. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 2006, 51-71. Elsevier, New York. 7th edition. G.J. Siegel (Ed.).
244. Raman L., Tkac I., Ennis K., Georgieff M.K., Gruetter R., Rao R. In vivo effect of chronic hypoxia on the neurochemical profile of the developing rat hippocampus. Brain Res. Dev. Brain Res. 2005, 156:202-209.
245. Rao R., Tkáč I., Townsend E.L., Gruetter R., Georgieff M.K. Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. J. Nutr. 2003, 133:3215-3221.
246. Rao R., Tkac I., Townsend E.L., Ennis K., Gruetter R., Georgieff M.K. Perinatal iron deficiency predisposes the developing rat hippocampus to greater injury from mild to moderate hypoxia-ischemia. J. Cereb. Blood Flow Metab. 2006, 27:729-740.
247. Ratering D., Baltes C., Nordmeyer-Massner J., Marek D., Rudin M. Performing of a 200-MHz cryogenic RF probe designed for MRI and MRS of the murine brain. Magn. Reson. Med. 2008, 59:1440-1447.
248. Rebec G.V., Pierce R.C. A vitamin as neuroregulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 1994, 43:537-565.
249. Rheims S., Holmgren C.D., Chazal G., Mulder J., Harkany T., Zilberter T., Zilberter Y. GABA action in immature neocortical neurons directly depends on the availability of keton bodies. J. Neurochem. 2009, 110:1330-1338.
250. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000, 23:209-216.
251. Rose S.E., de Zubicaray G.I., Wang D., Galloway G.J., Chalk J.B., Eagle S.C., Semple J., Doddrell D.M. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn. Reson. Imaging 1999, 17:291-299.
252. Rose S.J., Bushi M., Nagra I., Davies W.E. Taurine fluxes in insulin dependent diabetes mellitus and rehydration in streptozotocin treated rats. Adv. Exp. Med. Biol. 2000, 483:497-501.
253. Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat. Rec. 2001, 265:54-84.
254. 1H magnetic resonance spectroscopy study. NMR Biomed. 1988, 1:20-26.
255. Sager T.N., Fink-Jensen A., Hansen A.J. Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J. Neurochem. 1997, 68:675-682.
256. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004, 61:705-713.
257. Sappey-Marinier D., Calabrese G., Fein G., Hugg J.W., Biggins C., Weiner M.W. Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J. Cereb. Blood Flow Metab. 1992, 12:584-592.
258. Saravia F.E., Revsin Y., Gonzalez Deniselle M.C., Gonzalez S.L., Roig P., Lima A., Homo-Delarche F., De Nicola A.F. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res. 2002, 957:345-353.
259. Sarchielli P., Pelliccioli G.P., Tarducci R., Chiarini P., Presciutti O., Gobbi G., Gallai V. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001, 43:189-197.
260. Schneider E., Glover G. Rapid in vivo proton shimming. Magn. Reson. Med. 1991, 18:335-347.
261. Schuff N., Amend D.L., Knowlton R., Norman D., Fein G., Weiner M.W. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol. Aging 1999, 20:279-285.
262. 1H magnetic resonance spectroscopic imaging. Magn. Reson. Med. 2001, 45:899-907.
263. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., Kramer J., Jagust W., Miller B., Wolkowitz O.M., Yaffe K., Weiner M.W. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002, 58:928-935.
264. Seaquist E.R., Damberg G.S., Tkac I., Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001, 50:2203-2209.
265. Selkoe D.J. Deciphering Alzheimer's disease: molecular genetics and cell biology yield major clues. J. NIH Res. 1995, 7:57-64.
266. Server A., Kulle B., Gadmar O.B., Josefsen R., Kumar T., Nakstad P.H. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Eur. J. Radiol. 2010, 2010 Aug 12. [Epub ahead of print].
267. 3H]N-acethyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochem Int 2001, 38:53-62.
268. Shen J., Rothman D.L., Hetherington H.P., Pan J.W. Linear projection method for automatic slice shimming. Magn. Reson. Med. 1999, 42:1082-1088.
269. Shirayama Y., Obata T., Nonaka H., Matsuzawa D., Kanazawa Y., Yoshitome E., Ikehira H., Hashimoto K., Iyo M. Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage 2010, 49(3):2783-2790.
270. Sibtain N.A., Howe F.A., Saunders D.E. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin. Radiol. 2007, 62:109-119.
271. Simister R.J., McLean M.A., Barker G.J., Duncan J.S. A proton magnetic resonance spectroscopy study of metabolites in the occipital lobes in epilepsy. Epilepsia 2003, 44:550-558.
272. Simões R.V., García-Martín M.L., Cerdán S., Arús C. Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia. NMR Biomed. 2008, 21:251-264.
273. 1H-MRSI pattern perturbation in a mouse glioma: the effects of acute hyperglycemia and moderate hypothermia. NMR Biomed. 2010, 23:23-33.
274. Sivák S., Bittšanský M., Kurča E., Turčanová-Koprušáková M., Grofik M., Nosál' V., Poláček H., Dobrota D. Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 2010, 52:1079-1085.
275. Skerritt J.H., Johnston G.A. Postnatal development of GABA binding sites and their endogenous inhibitors in rat brain. Dev. Neurosci. 1982, 5:189-197.
276. Slotboom J., Boesch C., Kreis R. Verstile frequency domain fitting using time domain models and prior knowledge. Magn. Reson. Med. 1998, 39:899-911.
277. Storey E., Hyman B.T., Jenkins B., Brouillet E., Miller J.M., Rosen B.R., Beal M.F. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 1992, 58:1975-1978.
278. 1H MRSI. Neurology 2002, 58:773-779.
279. Tate A.R., Underwood J., Acosta D.M., Julià-Sapé M., Majós C., Moreno-Torres A., Howe F.A., van der Graaf M., Lefournier V., Murphy M.M., Loosemore A., Ladroue C., Wesseling P., Luc Bosson J., Cabañas M.E., Simonetti A.W., Gajewicz W., Calvar J., Capdevila A., Wilkins P.R., Bell B.A., Rémy C., Heerschap A., Watson D., Griffiths J.R., Arús C. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed. 2006, 19:411-434.
280. Taylor-Robinson S.D., Turjanski N., Bhattacharya S., Seery J.P., Sargentoni J., Brooks D.J., Bryant D.J., Cox I.J. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metab. Brain Dis. 1999, 14:45-55.
281. 1H-MRS). Schizophr. Res. 2009, 108:69-77.
282. Tedeschi G., Litvan I., Bonavita S., Bertolino A., Lundbom N., Patronas N.J., Hallett M. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 1997, 120:1541-1552.
283. 1H NMR detection of vitamin C in human brain in vivo. Magn. Reson. Med. 2004, 51:225-229.
284. Terpstra M., Gruetter R., High W.B., Mescher M., DelaBarre L., Merkle H., Garwood M. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res. 1998, 58:5083-5088.
285. Terpstra M., Anderson P., Gruetter Localized eddy current compensation using quantitative field mapping. J. Magn. Reson. 1998, 131:139-143.
286. Terpstra M., Ugurbil K., Gruetter R. Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7Tesla. Magn. Reson. Med. 2002, 47:1009-1012.
287. Terpstra M., Henry P.G., Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn. Reson. Med. 2003, 50:19-23.
288. Terpstra M., Vaughan T.J., Ugurbil K., Lim K.O., Schulz S.C., Gruetter R. Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. MAGMA 2005, 18:276-282.
289. Terpstra M., Tkác I., Rao R., Gruetter R. Quantification of vitamin C in the rat brain in vivo using short echo-time 1H MRS. Magn. Reson. Med. 2006, 55:979-983.
290. 1H NMR spectroscopy. NMR Biomed. 2010, 23:1038-1043.
291. 1H NMR spectroscopy of the mouse brain at 9.4T. Magn. Reson. Med. 2004, 52:478-484.
292. 1H NMR spectroscopy of rat brain at 1ms echo time. Magn. Reson. Med. 1999, 41:649-656.
293. 1H NMR spectroscopy. Magn. Reson. Med. 2003, 50:24-32.
294. 1H NMR spectroscopy. J. Neurochem. 2007, 100:1397-1406.
295. 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn. Reson. Med. 2009, 62:868-879.
296. Trachtman H., Futterweit S., Sturman J.A. Cerebral taurine transport is increased during streptozocin-induced diabetes in rats. Diabetes 1992, 41:1130-1140.
297. 1H nuclear magnetic resonance spectroscopy and biochemical characterization. Neuroscience 1997, 79:819-826.
298. Turner R., Chapman B., Howseman A.M., Ordidge R.J., Coxon R., Glover P., Mansfield Snap-shot magnetic resonance imaging at 0.1T using double-screened gradients. J. Magn. Reson. 1988, 80:248-258.
299. Turner O., Phoenix J., Wray S. Developmental and gestational changes of phosphoethanolamine and taurine in rat brain, striated and smooth muscle. Exp. Physiol. 1994, 79:681-689.
300. Tveden-Nyborg P., Johansen L.K., Raida Z., Villumsen C.K., Larsen J.O., Lykkesfeldt J. Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. Am. J. Clin. Nutr. 2009, 90:540-546.
301. van de Looij Y., Chatagner A., Hüppi P.S., Gruetter R., Sizonenko S.V. Longitudinal MR assessment of hypoxic ischemic injury in the immature rat brain. Magn. Reson. Med. 2011, 65:305-312.
302. van de Looij Y., Kunz N., Huppi P., Gruetter R., Sizonenko S. Diffusion tensor echo planar imaging using surface coil transceiver with a semiadiabatic RF pulse sequence at 14.1T. Magn. Reson. Med. 2011, 65:732-737.
303. 1 destructive interferences and spatial phase patterns at 7T with a head transceiver array coil. Magn. Reson. Med. 2005, 54:1503-1518.
304. 1H magnetic resonance spectroscopy. NMR Biomed. 2004, 17:405-410.
305. 31P MRS NMR signals using the variable projection method and prior knowledge. Magn. Reson. Med. 1988, 6:92-98.
306. Van Vaals J.J., Bergman A.H. Optimization of eddy-current compensation. J. Magn. Reson. 1990, 90:52-70.
307. Vanhamme L., Van den Boogaart A., Van Huffel S. Improved method for accurate and efficient quantification fMRS data with use of prior knowledge. J. Magn. Reson. 1997, 129:35-43.
308. Vannucci S.J., Seaman L.B., Brucklacher R.M., Vannucci R.C. Glucose transport in developing rat brain: glucose transporter proteins, rate constants and cerebral glucose utilization. Mol. Cell. Biochem. 1994, 140:177-184.
309. Verbalis, J.G., 2010. Brain volume regulation in response to changes in osmolality. Neuroscience 168(4):862-70.
310. Viau M., Marchand L., Bard C., Boulanger Y. 1H magnetic resonance spectroscopy of autosomal ataxias. Brain Res. 2005, 1049:191-202.
311. Wang S., Poptani H., Woo J.H., Desiderio L.M., Elman L.B., McCluskey L.F., Krejza J., Melhem E.R. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0T. Radiology 2006, 239:831-838.
312. Waniewski R.A., Martin D.L. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 1998, 18:5225-5233.
313. Wardlaw J.M., Marshall I., Wild J., Dennis M.S., Cannon J., Lewis S.C. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 1998, 29:1618-1624.
314. Watanabe T., Shiino A., Akiguchi I. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 2010, 30(1):71-77.
315. 1H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6T. MAGMA 2009, 22:53-62.
316. Westbrook G.L., Mayer M.L., Namboodiri M.A., Neale J.H. High concentrations of N-acethylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J. Neurosci. 1986, 6:3385-3392.
317. 31P magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono- and diesters at 3T in the human brain: relation with age and spatial differences. NMR Biomed. 2010, 23:968-976.
318. 13C-1-enriched glucose. Magn. Reson. Imaging 2010, 28:690-697.
319. Wright A.C., Song H.K., Wehrili F.W. In vivo MR micro imaging with conventional radiofrequency coils cooled to 77 degree K. Magn. Reson. Med. 2000, 43:163-169.
320. Xin L., Gambarota G., Mlynárik V., Gruetter R. Proton T2 relaxation time of J-coupled cerebral metabolites in rat brain at 9.4T. NMR Biomed. 2008, 21:396-401.
321. Xin L., Gambarota G., Duarte J.M.N., Mlynárik V., Gruetter R. Direct in vivo measurement of glycine and the neurochemical profile in the rat medulla oblongata. NMR Biomed. 2010, 23:1097-1102.
322. 13C] acetate at 14.1T. Magn. Reson. Med. 2010, 64:334-340.
323. 1H MRS at 11.7T. Neuroimage 2005, 28:401-409.
324. Yang J., Shen J. Increased oxygen consumption in the somatosensory cortex of alpha-chloralose anesthetized rats during forepaw stimulation determined using MRS at 11.7Tesla. Neuroimage 2006, 32:1317-1325.
325. Yao F.S., Caserta M.T., Wyrwicz A.M. In vitro proton and phosphorus NMR spectroscopic analysis of murine (C57Bl/6J) brain development. NMR Biomed. 1999, 12:463-470.
326. Yao J.K., Leonard S., Reddy R. Altered glutathione redox state in schizophrenia. Dis. Markers 2006, 22:83-93.
327. Yoo S.Y., Yeon S., Choi C.H., Kang D.H., Lee J.M., Shin N.Y., Jung W.H., Choi J.S., Jang D.P., Kwon J.S. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus. Schizophr. Res. 2009, 111:86-93.
328. Yoon J.H., Maddock R.J., Rokem A., Silver M.A., Minzenberg M.J., Ragland J.D., Carter C.S. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J. Neurosci. 2010, 30:3777-3781.
329. Zacharoff, L., Tkac, I., Song, Q., Tang, C., Bolan, P.J., Mangia, S., Henry, P.G., Li, T., Dubinsky, J.M., 2011. Cortical metabolites as biomarkers in the R6/2 model of Huntington's disease. J Cereb Blood Flow Metab. 2011 Nov 2. doi:. [Epub ahead of print]. doi:10.1038/jcbfm.2011.157.
330. Zand D.J., Simon E.M., Pulitzer S.B., Wang D.J., Wang Z.J., Rorke L.B., Palmieri M., Berry G.T. In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. AJNR Am. J. Neuroradiol. 2003, 24:1471-1474.
331. Zhang Y., Li S., Shen J. Automatic high-order shimming using parallel columns mapping (PACMAP). Magn. Reson. Med. 2009, 63:1073-1079.
332. 3H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. Eur. J. Neurosci. 2001, 13:340-346.
333. Zwingmann C., Butterworth R. An update of the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochem. Int. 2005, 47:19-30.